MCARH109
Showing 1 - 2 of 2
Multiple Myeloma, Refractory Multiple Myeloma, Relapse Multiple Myeloma Trial in New York (MCARH125, MCARH109)
Recruiting
- Multiple Myeloma
- +2 more
- MCARH125
- MCARH109
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jun 20, 2022
Multiple Myeloma Trial in New York (Infusion of MCARH109 T cells)
Active, not recruiting
- Multiple Myeloma
- Infusion of MCARH109 T cells
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jul 5, 2022